NCT00792727已完成3 期
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Four-Week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 380
- 试验地点
- 1
- 主要终点
- Change from the baseline of the WOMAC pain subscale score at Visit 6 (Day 14 ± 2 days)
研究概览
简要总结
Ketoprofen in a topical patch formulation has been demonstrated to be effective for treating mild to moderate pain caused by various musculoskeletal disorders.
详细描述
The objective of this study is to demonstrate the short-term multiple dose efficacy and safety of HKT-500 in subjects with pain caused by mild to moderate osteoarthritis of the knee. The goal of the study is to gather additional information about the analgesic efficacy and safety of repeated, 24-hour applications of 2 HKT-500 patches per knee for a total of 28 days in subjects with pain caused by mild to moderate osteoarthritis of the knee.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 45 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •man or woman ≥45 years of age.
- •clinical diagnosis of unilateral or bilateral OA of the knee
- •taking an NSAID or acetaminophen on a regular basis and has a history of knee pain amelioration with NSAID or acetaminophen use.
- •mild to moderate OA of the knee at the screening visit
- •subject exhibits an arthritis "flare" in the target knee within 7 days day of withdrawing from a NSAID or acetaminophen.
- •subject understands that treatment will be administered on an inpatient basis.
- •subject is capable of understanding and complying with the protocol and has signed the informed consent document.
排除标准
- •subject is a woman of childbearing potential who has a positive urine pregnancy test, is lactating, or who is not surgically sterile
- •subject has symptoms that are attributable to primary inflammatory diseases of the joint
- •subject has unstable knees including a history of the knee catching or giving way or physical examination evidence of instability
- •subject has arthropathies that occur in conjunction with systemic diseases
- •subject has a chronic pain condition
- •subject is grossly obese
- •subject has a history of knee surgery within the past 12 months or arthroscopy within the past 6 months.
- •subject has a history of osteotomies.
- •subject is not willing to discontinue the use of NSAIDs, acetaminophen or other prohibited treatments
- •subject used opioids for OA pain within 1 month
研究组 & 干预措施
Ketoprofen Patch
Experimental
Treatment with experimental drug
干预措施: ketoprofen Patch (Drug)
Placebo Patch
Placebo Comparator
Treatment with placebo drug
干预措施: Placebo Patch (Other)
结局指标
主要结局
Change from the baseline of the WOMAC pain subscale score at Visit 6 (Day 14 ± 2 days)
时间窗: 14 days ± 2 days
次要结局
- WOMAC: Change from the baseline of the pain subscale score at Visit 5 (Day 7 ±1 day), Visit 7 (Day 21 ±3 days) and Visit 8 (Day 28 ±3 days)(28 days (±3 days))
- WOMAC: Change from the baseline of the subscale scores for stiffness and physical function at Visit 5, Visit 6, Visit 7 and Visit 8(28 days (±3 days))
- WOMAC: Change from the baseline of the composite score at Visit 5, Visit 6, Visit 7 and Visit 8(28 days (±3 days))
- Pain Intensity differences at rest, on motion and of overall assessment using a VAS scale at each follow-up assessments time point through Day 28.(28 days)
- Subject's Global Assessment at Visit 6 and Visit 8(28 days (±3 days))
- Investigator's Global Assessment at Visit 6 and Visit 8(28 days (±3 days))
研究者
研究点 (1)
Loading locations...
相似试验
终止
3 期
Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or BursitisTendonitisBursitisNCT00426985APR Applied Pharma Research s.a.381
已完成
3 期
Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or BursitisTendonitisBursitisNCT00352625APR Applied Pharma Research s.a.330
已完成
3 期
Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or StrainStrainSprainNCT00351104APR Applied Pharma Research s.a.200
Unknown
3 期
The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute MigraineMigraine DisordersMigraine HeadacheAcute MigraineMigraineNCT01228552Behar, Caren, M.D.100
撤回
3 期
Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue InjurySprainNCT01223053Imprimis Pharmaceuticals, Inc.